Bearing Point Capital LLC raised its stake in Danaher Corporation (NYSE:DHR - Free Report) by 6.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 35,510 shares of the conglomerate's stock after acquiring an additional 2,184 shares during the period. Danaher makes up 1.5% of Bearing Point Capital LLC's portfolio, making the stock its 17th biggest position. Bearing Point Capital LLC's holdings in Danaher were worth $7,280,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently modified their holdings of the company. Bank Pictet & Cie Europe AG lifted its holdings in Danaher by 22.8% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock valued at $44,241,000 after acquiring an additional 35,730 shares during the period. Modern Wealth Management LLC raised its stake in Danaher by 30.5% during the 4th quarter. Modern Wealth Management LLC now owns 1,087 shares of the conglomerate's stock valued at $250,000 after purchasing an additional 254 shares during the period. Financial Engines Advisors L.L.C. grew its holdings in Danaher by 19.8% during the 4th quarter. Financial Engines Advisors L.L.C. now owns 1,137 shares of the conglomerate's stock valued at $261,000 after buying an additional 188 shares in the last quarter. AssuredPartners Investment Advisors LLC purchased a new position in Danaher during the 4th quarter valued at approximately $365,000. Finally, Orion Portfolio Solutions LLC boosted its holdings in shares of Danaher by 9.0% in the 4th quarter. Orion Portfolio Solutions LLC now owns 77,009 shares of the conglomerate's stock worth $17,678,000 after purchasing an additional 6,359 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research firms recently issued reports on DHR. The Goldman Sachs Group dropped their price objective on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Royal Bank Of Canada restated an "outperform" rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday, April 23rd. HSBC decreased their price target on Danaher from $270.00 to $240.00 in a research note on Friday, April 25th. Bank of America cut their price objective on Danaher from $265.00 to $230.00 in a report on Monday, April 14th. Finally, Citigroup reaffirmed a "buy" rating on shares of Danaher in a report on Monday, April 7th. Three equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $247.61.
Check Out Our Latest Stock Report on Danaher
Insiders Place Their Bets
In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman directly owned 3,105,808 shares of the company's stock, valued at $611,036,665.92. The trade was a 28.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president directly owned 15,179 shares of the company's stock, valued at $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 11.20% of the company's stock.
Danaher Trading Up 1.9%
Danaher stock traded up $3.89 during trading on Tuesday, reaching $206.83. 4,973,033 shares of the company were exchanged, compared to its average volume of 4,283,576. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $281.70. The company has a market capitalization of $148.10 billion, a P/E ratio of 44.01, a PEG ratio of 2.86 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The stock's 50 day simple moving average is $196.51 and its two-hundred day simple moving average is $203.22.
Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The business had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. During the same period in the previous year, the firm posted $1.72 earnings per share. The company's revenue was up 3.4% on a year-over-year basis. On average, equities research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, July 25th. Investors of record on Friday, June 27th were issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.62%. Danaher's dividend payout ratio (DPR) is presently 27.23%.
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles

Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report